Metagenomi Therapeutics, Inc. (MGX)

NASDAQ

$1.05

$+0.01

(+1.26%)

Pre-Market

Metagenomi Therapeutics, Inc. (MGX) Live Price Chart

Last updated: ⁦2026-10-13 09:21:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Metagenomi Therapeutics, Inc. (MGX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $1.05, with a market capitalisation of $37.78M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.96 to $3.95. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$37.78M
Open	$1.03
Day's High	$12.74
Day's Low	$0.96
Previous Close	$1.02
Volume	--
Average Volume	150.67K
P/E Ratio	--
52-Week High	$3.95
52-Week Low	$0.96
Dividend Yield	--
Earnings Date	--

Metagenomi Therapeutics, Inc. (MGX) Pre-Market Stock Price

Metagenomi Therapeutics, Inc. (MGX) is trading at $1.05 in pre-market trading as of 2026-10-13 08:10:00, up 2.45% ($0.02) from the previous close of $1.02

Pre-market trading shows how investors are pricing MGX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Metagenomi Therapeutics, Inc. (MGX) 7-Day Stock Price Change

Over the past seven days, Metagenomi Therapeutics, Inc. (MGX) moved from $1.02 to $1.05, representing a gain of 2.45% ($0.02).

The stock traded between $0.96 and $1.10 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 189.93 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

MGX 52-Week Price Position

Position in Range: 2.8%

52W Low$0.96

52W High$3.95

MGX is currently trading at $1.05, placing it 2.8% of the way from its 52-week low of $0.96 to its 52-week high of $3.95. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Metagenomi Therapeutics, Inc. (MGX)?

Metagenomi Therapeutics Inc is an vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. The company leverages machine learning and artificial intelligence to enhance its signature gene editing systems. MGX-001 is its, wholly-owned development program in hemophilia A, where the company have demonstrated targeted genome editing and durable gene expression from a one-time treatment in non-human primates (NHPs) and an overall profile potentially competitive with best-in-class treatment options. MGX-001 is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia A from a single administration.

Metagenomi Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	113
Exchange	NASDAQ
Company Website	https://metagenomi.co

How to Buy Metagenomi Therapeutics, Inc. (MGX) Stock on MEXC

Eligible investors can buy real shares of Metagenomi Therapeutics, Inc. (MGX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for MGX and Place Your Order

Open the RealStocks trading page and search for MGX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Metagenomi Therapeutics, Inc. (MGX) stock price today?

Metagenomi Therapeutics, Inc. (MGX) is currently trading at $ 1.05, up 2.45% ($0.02) from the previous close of $ 1.02. Intraday prices update in real time during regular trading hours.

2.Is MGX stock going up or down today?

As of 2026-10-13 08:10:00, MGX is trading at $ 1.05, up 2.45% ($0.02) from its previous close of $ 1.02. The stock has traded between $ 0.96 and $ 12.74 during today’s regular session. Past price movements do not guarantee future results.

3.What is MGX pre-market price?

As of 2026-10-13 08:10:00, MGX is trading at $ 1.05 in pre-market trading, up 2.45% ($0.02) from the previous close of $ 1.02. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is MGX after-hours price?

As of 2026-10-13 08:10:00, MGX is trading at $ 1.03 in after-hours trading, up 0.88% ($0.01) from the regular-session close of $ 1.02. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is MGX stock trading now?

MGX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does MGX sit relative to its 52-week high and low?

Over the past 52 weeks, MGX has traded between a low of $ 0.96 and a high of $ 3.95. At $ 1.05, the stock is positioned 2.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Metagenomi Therapeutics, Inc. in?

Metagenomi Therapeutics, Inc. (MGX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Metagenomi Therapeutics, Inc.'s market capitalisation and where is it listed?

Metagenomi Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 37.78M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is MGX valued in terms of P/E ratio and EPS?

MGX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.47. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Metagenomi Therapeutics, Inc. pay a dividend?

Metagenomi Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.